Pathways for Nasal Delivery

Summary: The nasal pathway offers an optimal alternative to traditional routes of administration such as oral and parenteral for conditions where it can provide a faster onset of action and a more convenient one. Nasal administration can have multiple configurations from unit-dose and bi-dose for more acute treatments to multi-dose for chronic usage. Nasal development is an attractive option but can be difficult, requiring expertise to overcome formulation challenges, and to navigate the complexities of drug/device combination products to optimize drug delivery.

Catalent is a leader in nasal delivery, offering end-to-end solutions for the development and manufacture of nasal drug products. As a trusted CDMO with a strong track record in successfully developing and commercializing nasal drug products to support both U.S. and global markets, partner with Catalent to bring your nasal therapy from concept to market and to patients.